FTC Says Supplement Maker to Pay $5.5M on False Advertising Charges
The Federal Trade Commission is requiring a Health Sciences U.S.A. and two affiliated Canadian companies to pay $5.5 million to settle charges that it falsely advertised that its dietary supplements could help consumers lose weight and treat or prevent colds…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
and other illnesses. The $5.5 million will be used for refunds to consumers who purchased Accelis, nanoSLIM, and any Cold MD, Germ MD, and Allergy MD product. These supplements were sold over the Internet and were widely available at retail stores. In addition, the settlement requires the marketer to stop making deceptive health claims about the products.